Annexon, Inc.
ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF
Last updated:
Abstract:
The present invention provides anti-C1q antibodies and methods of using the same.
Status:
Application
Type:
Utility
Filling date:
10 Feb 2021
Issue date:
9 Sep 2021